grant | 2025 - 2026
Allele selective LRRK2 targeted antisense oligonucleotide therapeutic development for Parkinsons Disease
Perron Institute for Neurological and Translational Science
Grant no. 22599.
grant | 2025 - 2028
Co-development of genetic targets and antisense oligonucleotides for the treatment of amyotrophic lateral sclerosis
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 23136.
grant | 2024 - 2025
Does Charge Matter - Investigating the Biodistribution of Morpholinos and Thio-Morpholinos
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 21949.
grant | 2023 - 2023
Allele selective FUS targeted Antisense Oligonucleotide therapeutic development for ALS
Perron Institute for Neurological and Translational Science
Grant no. 21518.